A case report described persistent catatonia during several treatment attempts. A benzodiazepine’s presence in the earlier regimen did not establish a controlled test of the entire drug class.
The patient had stupor, withdrawal, insomnia, and poor intake. Risperidone and flunitrazepam were used before further treatment with other antipsychotics and electroconvulsive therapy.
Symptoms remained difficult to control, and the benefit from ECT did not persist for a month. The authors later reported substantial improvement with low-dose aripiprazole.
Medication combinations, duration, illness course, and adverse effects complicate attribution. Failure of one regimen cannot establish that every benzodiazepine strategy would fail, and later improvement does not isolate a mechanism.
This single case is useful for describing treatment resistance and the need to reconstruct prior trials carefully. It cannot estimate response rates or establish aripiprazole as universally preferable for catatonia. An accurate account should identify the actual agent and treatment sequence rather than summarizing the case as simple benzodiazepine failure.
Original analysis of the supplied journal article, identified as PMC3473267.